Company Analysis

Vericel Corporation (VCEL)

Nasdaq: VCEL · Biological Products, (No Diagnostic Substances) · Cambridge, MA · filing with the SEC since 1996
Grade7.2
◀ Past 7.4● Present 8.1▶ Future 5.7

Who runs Vericel Corporation

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Colangelo Dominick
President and CEO. First filing Mar 2013, latest Feb 26, 2026, 24 filings in all.
Officers reporting now
7
of 13 people with a filing in the last fifteen months
Directors reporting now
6
17 people on the record since 2006
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Mara Joseph Anthony JrChief Financial OfficerJan 2021Nov 12, 20268 · $4.6M
Flynn Sean C.Chief Legal OfficerFeb 2020Nov 6, 20265 · $2.8M
Siegal JonathanPrincipal Accounting OfficerMar 2022Nov 6, 20268 · $600,000
Halpin MichaelChief Operating OfficerJun 2019Aug 5, 20264 · $1.6M
Hopper Jonathan MarkChief Medical OfficerFeb 2020Jun 30, 20265 · $800,000
Colangelo DominickPresident and CEOMar 2013Feb 26, 2026none
Mahoney KarenChief Human Resources OfficerFeb 2025Dec 12, 2025none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Mclaughlin Kevin FdirectorJan 2015Nov 12, 20265 · $1.2M
Zerbe Robert L MddirectorJan 2006Nov 12, 20264 · $400,000
Wotton Paul KdirectorJan 2015May 13, 20264 · $500,000
Hagen HeididirectorAug 2013May 1, 20261 · $500,000
Rubino Alan LdirectorNov 2006May 1, 2026none
Wright LisadirectorJun 2021May 1, 2026none
Earlier names on the record7, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton VCEL · research, not advice